BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben-ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-kaspa R, Klein T. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterology 2003;98:144-50. [DOI: 10.1111/j.1572-0241.2003.07179.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 165] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. Journal of Leukocyte Biology 2006;80:1197-213. [DOI: 10.1189/jlb.0506297] [Cited by in Crossref: 182] [Cited by in F6Publishing: 177] [Article Influence: 11.4] [Reference Citation Analysis]
2 Liu Y, Gao S, Du B, Wang J. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis. Tumor Biol 2014;35:3551-61. [DOI: 10.1007/s13277-013-1469-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shaw T, Locarnini S. Entecavir for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther. 2004;2:853-871. [PMID: 15566330 DOI: 10.1586/14789072.2.6.853] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
4 Nard FD, Todoerti M, Grosso V, Monti S, Breda S, Rossi S, Montecucco C, Caporali R. Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs. World J Hepatol 2015; 7(3): 344-361 [PMID: 25848463 DOI: 10.4254/wjh.v7.i3.344] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
5 Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005;42:505-510. [PMID: 15763337 DOI: 10.1016/j.jhep.2004.11.026] [Cited by in Crossref: 106] [Cited by in F6Publishing: 114] [Article Influence: 5.9] [Reference Citation Analysis]
6 Huang J, Xiong L, Wang J, Liu Y, Zhu Q, Lei J, Zhou Z. Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis. Biomed Rep 2016;4:557-66. [PMID: 27123247 DOI: 10.3892/br.2016.632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 El-Sherbini SM, Shahen SM, Mosaad YM, Abdelgawad MS, Talaat RM. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai) 2013;45:330-8. [PMID: 23399816 DOI: 10.1093/abbs/gmt003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yang H, He X, Song Q, Chen M, Li J, Wang M, Yu J, Yao J, Liu L, Lin J. Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B: EphA3 polymorphism and HBV infection. Hepatology Research 2012;42:790-7. [DOI: 10.1111/j.1872-034x.2012.00977.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, Eslamifar A, Jourabchi A, Farazi AA, Ramezani A. No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome. Hepat Mon 2013;13:e8803. [PMID: 23922563 DOI: 10.5812/hepatmon.8803] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
10 Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol 2012; 4(3): 105-109 [PMID: 22489263 DOI: 10.4254/wjh.v4.i3.105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
11 Dondeti MF, Abdelkhalek MS, El-din Elezawy HM, Alsanie WF, Raafat BM, Gamal-eldeen AM, Talaat RM. Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV). J Appl Biomed. [DOI: 10.32725/jab.2022.001] [Reference Citation Analysis]
12 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
13 Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat. 2007;14:841-848. [PMID: 18070287 DOI: 10.1111/j.1365-2893.2007.00880.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 48] [Article Influence: 0.6] [Reference Citation Analysis]
14 Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA. Transforming Growth Factor- β 1 Gene Polymorphism (T29C) in Egyptian Patients with Hepatitis B Virus Infection: A Preliminary Study. Hepat Res Treat. 2013;2013:293274. [PMID: 24455227 DOI: 10.1155/2013/293274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, Chen YP. Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis. 2010;14:e580-e585. [PMID: 20004605 DOI: 10.1016/j.ijid.2009.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
16 Kazemi S, Saidijam M, Hashemi SH, Karami M, Vaisi-Raygani A, Alikhani MY. Analysis of IL-10 and IL-6 Gene Polymorphisms and Their Serum Levels in Patients with Brucellosis: A Case Control Study. Immunol Invest 2016;45:107-15. [PMID: 26849072 DOI: 10.3109/08820139.2015.1096285] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
17 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
18 Yang ZT, Zhang XX, Kong XF, Zhang DH, Zhang SY, Jiang JH, Gong QM, Jin GD, Lu ZM. Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients. World J Gastroenterol 2008; 14(35): 5454-5460 [PMID: 18803359 DOI: 10.3748/wjg.14.5454] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Zheng L, Li D, Wang F, Wu H, Li X, Fu J, Chen X, Wang L, Liu Y, Wang S. Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene. J Clin Immunol. 2010;30:855-860. [PMID: 20700634 DOI: 10.1007/s10875-010-9450-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
20 Chung RT. Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B. Cancer 2005;103:654-6. [PMID: 15641028 DOI: 10.1002/cncr.20837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
21 Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol 2016; 8(10): 485-498 [PMID: 27057306 DOI: 10.4254/wjh.v8.i10.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
22 Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, Reis MG. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008;80:58-64. [PMID: 18041006 DOI: 10.1002/jmv.21011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
23 King Thomas J, Mir H, Kapur N, Singh S. Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer. Cancers (Basel) 2019;11:E1857. [PMID: 31769418 DOI: 10.3390/cancers11121857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
24 Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, Rahoud S, Mergani A, Henri S, Gaudart J, Mohamed-Ali Q, Young HA, Dessein AJ. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003;171:5596-601. [PMID: 14607968 DOI: 10.4049/jimmunol.171.10.5596] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
25 Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. 2015;112:2175-2180. [PMID: 25646429 DOI: 10.1073/pnas.1424775112] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 15.7] [Reference Citation Analysis]
26 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Wu SM, Yang HF, Zhang M, Xiong Y, Han XQ, Yin JD, Zhou X, Cai CL. A561C and G98T polymorphisms and plasma soluble levels of E-selectin in patients with chronic HBV infection. Shijie Huaren Xiaohua Zazhi 2009; 17(12): 1253-1259 [DOI: 10.11569/wcjd.v17.i12.1253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Del Vecchio A, Laforgia N, Capasso M, Iolascon A, Latini G. The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis. Clinics in Perinatology 2004;31:53-67. [DOI: 10.1016/j.clp.2004.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
29 Seshasubramanian V, Soundararajan G, Ramasamy P. Human leukocyte antigen A, B and Hepatitis B infection outcome: A meta-analysis. Infect Genet Evol 2018;66:392-8. [PMID: 28757339 DOI: 10.1016/j.meegid.2017.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tunçbilek S. Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol 2014; 20(20): 6226-6235 [PMID: 24876743 DOI: 10.3748/wjg.v20.i20.6226] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
31 Sun Y, Lu Y, Li T, Xie L, Deng Y, Li S, Qin X. Interferon Gamma +874T/A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases: Evidence from a Meta-Analysis. PLoS One 2015;10:e0121168. [PMID: 25939029 DOI: 10.1371/journal.pone.0121168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ma N, Zhang X, Yang L, Zhou J, Liu W, Gao X, Yu F, Zheng W, Ding S, Gao P, Yuan M, Liu D. Role of Functional IFNL4, IFNLR1, IFNA, IFNAR2 Polymorphisms in Hepatitis B virus-related liver disease in Han Chinese population. J Viral Hepat 2018;25:306-13. [PMID: 29080269 DOI: 10.1111/jvh.12817] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
33 He XX, Chang Y, Jiang HJ, Tang F, Meng FY, Xie QH, Li PY, Song YH, Lin JS. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol 2010;23:251-7. [PMID: 20565290 DOI: 10.1089/vim.2009.0102] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
34 Talaat RM, Esmail AA, Elwakil R, Gurgis AA, Nasr MI. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients. Chin J Cancer. 2012;31:29-35. [PMID: 22200181 DOI: 10.5732/cjc.011.10258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
35 Vandenbroeck K, Goris A. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends in Pharmacological Sciences 2003;24:284-9. [DOI: 10.1016/s0165-6147(03)00131-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
36 Karakus N, Kara N, Ulusoy AN, Özaslan C, Bek Y. Tumor Necrosis Factor Alpha and Beta and Interferon Gamma Gene Polymorphisms in Turkish Breast Cancer Patients. DNA and Cell Biology 2011;30:371-7. [DOI: 10.1089/dna.2010.1113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
37 Wang J, Liu Y, Xie L, Li S, Qin X. Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study. Clin Res Hepatol Gastroenterol 2016;40:288-96. [PMID: 26546176 DOI: 10.1016/j.clinre.2015.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
38 Zhao YR, Gong L, He YL, Liu F, Lu C. Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B. World J Gastroenterol 2005; 11(6): 854-857 [PMID: 15682480 DOI: 10.3748/wjg.v11.i6.854] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13(12): 1770-1787 [PMID: 17465466 DOI: 10.3748/wjg.v13.i12.1770] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 135] [Article Influence: 9.2] [Reference Citation Analysis]
40 Dierksheide JE, Baiocchi RA, Ferketich AK, Roychowdhury S, Pelletier RP, Eisenbeis CF, Caligiuri MA, VanBuskirk AM. IFN-γamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. Blood. 2005;105:1558-1565. [PMID: 15498860 DOI: 10.1182/blood-2003-07-2476] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
41 Naslednikova IO, Konenkov VI, Ryazantseva NV, Novitskii VV, Tkachenko SB, Zima AP, Avdoshina VV, Beloborodova EI, Beloborodova EV, Dortman VV. Role of genetically determined production of immunoregulatory cytokines in immunopathogenesis of chronic viral hepatitides. Bull Exp Biol Med 2007;143:706-12. [DOI: 10.1007/s10517-007-0220-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
42 Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, Ge R, Mei Y, Shen BB, Duan ZH. A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection. 2011;39:21-27. [PMID: 21246248 DOI: 10.1007/s15010-010-0075-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
43 Zhang G, Wang W, Li S, Yang H, Zhang M, Zhang P, Wen Y, Wu A, Yang L, Zhou B, Chen X. IL6 gene allele-specific C/EBPα-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun 2015;16:528-35. [PMID: 26447433 DOI: 10.1038/gene.2015.40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
44 Ghaleh Baghi S, Alavian SM, Mehrnoush L, Salimi S. Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection. Hepat Mon 2015;15:e28287. [PMID: 26300930 DOI: 10.5812/hepatmon.28287v2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Gong QM, Kong XF, Yang ZT, Xu J, Wang L, Li XH, Jin GD, Gao J, Zhang DH, Jiang JH. Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection. J Viral Hepat. 2009;16:674-680. [PMID: 19714778 DOI: 10.1111/j.1365-2893.2009.01130.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
46 Chen DQ, Zeng Y, Zhou J, Yang L, Jiang S, Huang JD, Lu L, Zheng BJ. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol. 2010;82:371-378. [PMID: 20087947 DOI: 10.1002/jmv.21716] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
47 Gao X, Liu W, Zhang X, Tang L, Wang L, Yan L, Yang H, Li T, Yang L, Ma N, Liu D. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China. Tumour Biol 2016;37:12103-11. [PMID: 27209411 DOI: 10.1007/s13277-016-5077-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
48 Wang L, Lin SJ, Tsai JH, Tsai CH, Tsai CC, Yang CC. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccinees. Med Microbiol Immunol 2005;194:33-8. [PMID: 15278448 DOI: 10.1007/s00430-004-0225-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
49 Akgöllü E. Assessment of HLADP gene rs3128917 and rs9380343 polymorphisms in chronic HBV infection. Turk J Gastroenterol 2019;30:616-23. [PMID: 31290749 DOI: 10.5152/tjg.2019.18480] [Reference Citation Analysis]
50 Wang Q, Zhang C, Walayat S, Chen HW, Wang Y. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. European Journal of Obstetrics & Gynecology and Reproductive Biology 2011;158:330-3. [DOI: 10.1016/j.ejogrb.2011.05.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
51 Li H, Liu F, Zhu H, Zhou X, Lu J, Chang H, Hu J. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma. Med Sci Monit 2016;22:549-53. [PMID: 26893439 DOI: 10.12659/msm.895101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
52 Höhler T, Reuss E, Freitag CM, Schneider PM. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology. 2005;42:72-76. [PMID: 15918171 DOI: 10.1002/hep.20740] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
53 Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53:422-428. [PMID: 21274863 DOI: 10.1002/hep.24048] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
54 Peng XM, Huang YS, Ma HH, Gu L, Xie QF, Gao ZL. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int. 2006;26:326-333. [PMID: 16584395 DOI: 10.1111/j.1478-3231.2005.01241.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
55 Devi SG, Kumar A, Kar P, Husain SA, Sharma S. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy: Cytokine Gene Polymorphisms and HEV Infection. J Med Virol 2014;86:1366-76. [DOI: 10.1002/jmv.23925] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
56 Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol 2021;:e2189. [PMID: 33724604 DOI: 10.1002/rmv.2234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Peng XM, Lei RX, Gu L, Ma HH, Xie QF, Gao ZL. Influences of MxA gene -88 G/T and IFN-gamma +874 A/T on the natural history of hepatitis B virus infection in an endemic area. Int J Immunogenet 2007;34:341-6. [PMID: 17845304 DOI: 10.1111/j.1744-313X.2007.00696.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
58 Cui JJ, Zeng Z, Tian GB, Tian D, Lu HY. Advance in genetic factors influencing hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2007; 15(11): 1246-1251 [DOI: 10.11569/wcjd.v15.i11.1246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Gidvani V, Ramkissoon S, Sloand EM, Young NS. Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol 2007;82:721-4. [DOI: 10.1002/ajh.20881] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
60 Guo Y, Zang C, Li Y, Yuan L, Liu Q, Zhang L, Li S. Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis. Genet Test Mol Biomarkers 2013;17:814-20. [PMID: 24016252 DOI: 10.1089/gtmb.2013.0268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
61 Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, Hsu PN. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One. 2014;9:e103008. [PMID: 25047809 DOI: 10.1371/journal.pone.0103008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
62 Singh H, Samani D, Ghate MV, Gangakhedkar RR. Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progression. J Gene Med 2018;20:e3004. [PMID: 29282802 DOI: 10.1002/jgm.3004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Eurich D, Neumann UP, Boas-knoop S, Neuhaus R, Kiessling A, Yahyazadeh A, Trautwein C, Wasmuth H, Puhl G, Neuhaus P, Bahra M. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease: YKL-40-variants and liver transplantation. J Gastroenterol Hepatol 2013;28:153-60. [DOI: 10.1111/j.1440-1746.2012.07270.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
64 Sun XR, Wu J, Tang KF. The interferon-gamma (IFN-γ) +874T allele reduces the risk of hepatitis B infection in an Asian population. J Viral Hepat 2014;21:281-7. [PMID: 24597696 DOI: 10.1111/jvh.12140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011;31:1118-1126. [PMID: 21745278 DOI: 10.1111/j.1478-3231.2011.02507.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
66 Basturk B, Yavascaoglu I, Oral B, Göral G, Oktay B. Cytokine gene polymorphisms can alter the effect of Bacillus Calmette-Guérin (BCG) immunotherapy. Cytokine 2006;35:1-5. [PMID: 16938461 DOI: 10.1016/j.cyto.2006.06.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
67 Xia P, Zhou M, Dong DS, Xing YN, Bai Y. Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis. Tumour Biol 2014;35:1129-37. [PMID: 24026885 DOI: 10.1007/s13277-013-1151-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
68 Chinniah R, Sevak V, Pandi S, Ravi PM, Vijayan M, Kannan A, Karuppiah B. HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM. Immunogenetics 2021;73:291-305. [PMID: 33754173 DOI: 10.1007/s00251-021-01212-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ, Hu YX, Mu M, Wang B. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep. 2015;5:14933. [PMID: 26462556 DOI: 10.1038/srep14933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
70 El-maadawy EA, Talaat RM, Ahmed MM, El-shenawy SZ. Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in Egyptians. Human Immunology 2019;80:208-14. [DOI: 10.1016/j.humimm.2018.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
71 Dondeti MF, El-Maadawy EA, Talaat RM. Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol 2016; 22(30): 6800-6816 [PMID: 27570418 DOI: 10.3748/wjg.v22.i30.6800] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
72 Chen SH, Wu HL, Kao JH, Hwang LH. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors. PLoS One. 2012;7:e36984. [PMID: 22615863 DOI: 10.1371/journal.pone.0036984] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
73 Khanizadeh S, Ravanshad M, Mohebbi SR, Naghoosi H, Abrahim Tahaei M, Mousavi Nasab SD, Romani S, Azimzadeh P, Sanati A, Zali MR. Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-γ) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population. Hepat Mon. 2012;12:e7283. [PMID: 23300496 DOI: 10.5812/hepatmon.7283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
74 Howell JA, Visvanathan K, Kowdley K, Mccaughan G, Trautwein C. A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: A genomewide association study. Hepatology 2009;50:647-9. [DOI: 10.1002/hep.23147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
75 Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11:52-56. [PMID: 15649304 DOI: 10.1111/j.1469-0691.2004.01029.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
76 Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, Zhang R, Yao Z, Shen Y, Qiang B. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology. 2004;40:318-326. [PMID: 15368436 DOI: 10.1002/hep.20318] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 3.8] [Reference Citation Analysis]
77 Kaleli I, Demir M, Cevahir N, Yilmaz M, Demir S. Serum neopterin levels in patients with replicative and nonreplicative HBV carriers. BMC Infect Dis 2006;6:157. [PMID: 17076882 DOI: 10.1186/1471-2334-6-157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
78 Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol 2021;1318:91-107. [PMID: 33973174 DOI: 10.1007/978-3-030-63761-3_6] [Reference Citation Analysis]
79 Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y. Interleukin-1β gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 2006; 12(5): 776-779 [PMID: 16521194 DOI: 10.3748/wjg.v12.i5.776] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
80 Jung KW, Ha E, Yu GI, Kim SJ, Chung WJ, Jang BK, Lee JJ, Shin DH, Hwang JS. TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clinica Chimica Acta 2009;407:16-9. [DOI: 10.1016/j.cca.2009.06.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
81 Karim F, Rahman S, Khan M, Khorshed Alam A, Ahmed N, Zaki K, Mamun-al-mahtab, Debnath CR. Serum Interleukin-10 Level in Patients with Chronic Hepatitis B Infection. Hungarian Medical Journal 2007;1:241-50. [DOI: 10.1556/hmj.1.2007.2.11] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Chong WP, Ip WK, Tso GH, Ng MW, Wong WH, Law HK, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Peiris JS, Lau YL. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis 2006;6:82. [PMID: 16672072 DOI: 10.1186/1471-2334-6-82] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
83 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
84 Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2003;2:3. [PMID: 12809559 DOI: 10.1186/1477-3163-2-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
85 Sun Q, Guo X, Wang Q, Zhao F. The association of TNF-308 (G/A) gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis. Chin J Cancer Res 2016;28:536-42. [PMID: 27877013 DOI: 10.21147/j.issn.1000-9604.2016.05.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
86 Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H, Hashemi M. The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection. Hepat Mon 2016;16:e34266. [PMID: 27226800 DOI: 10.5812/hepatmon.34266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
87 Ribeiro CS, Visentainer JE, Moliterno RA. Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz 2007;102:435-40. [PMID: 17612762 DOI: 10.1590/s0074-02762007005000043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
88 Chan HL, Tse AM, Chim AM, Wong VW, Choi PC, Yu J, Zhang M, Sung JJ. Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B. J Gastroenterol Hepatol. 2008;23:783-789. [PMID: 17645476 DOI: 10.1111/j.1440-1746.2007.05110.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
89 Guo XF, Wang J, Yu SJ, Song J, Ji MY, Cao Z, Zhang JX, Wang J, Dong WG. TNF-α-308 polymorphism and risk of digestive system cancers: A meta-analysis. World J Gastroenterol 2013; 19(48): 9461-9471 [PMID: 24409077 DOI: 10.3748/wjg.v19.i48.9461] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
90 Qin H, Liu B, Shi T, Liu Y, Sun Y, Ma Y. Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis. J Int Med Res. 2010;38:760-768. [PMID: 20819413 DOI: 10.1177/147323001003800304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
91 Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet. 2006;44:246-255. [PMID: 16944293 DOI: 10.1007/s10528-006-9029-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
92 Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population. Biochem Genet 2014;52:387-402. [PMID: 24838671 DOI: 10.1007/s10528-014-9655-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
93 Ghasemian N, Shahbazi M. Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran. Jundishapur J Microbiol 2016;9:e33639. [PMID: 27800132 DOI: 10.5812/jjm.33639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
94 Al-Mohaya MA, Al-Otaibi L, Al-Harthi F, Al Bakr E, Arfin M, Al-Asmari A. Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility. BMC Oral Health 2016;16:76. [PMID: 27544215 DOI: 10.1186/s12903-016-0277-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
95 Zhang XL, Ni XC, Jia JH, Dong JH, Yu FX, Ma N, Liu XH, Li M, Liu DW. Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis. Scand J Gastroenterol. 2013;48:736-744. [PMID: 23601003 DOI: 10.3109/00365521.2013.787643] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
96 Tuncbilek S, Aydin K, Hizel K. Vitamin D and Tumor Necrosis Factor-Alpha Receptor Gene Polymorphisms in Various Hepatitis B Clinical Conditions in Turkey. Gastroenterology Res 2013;6:185-90. [PMID: 27785252 DOI: 10.4021/gr544e] [Reference Citation Analysis]
97 Imran M, Manzoor S, Khattak NM, Tariq M, Khalid M, Javed F, Bhatti S. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan. Viral Immunol. 2014;27:105-111. [PMID: 24673406 DOI: 10.1089/vim.2013.0107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
98 Liu M, Cao B, Zhang H, Dai Y, Liu X, Xu C. Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics 2006;58:859-64. [PMID: 17033822 DOI: 10.1007/s00251-006-0161-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
99 Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, Hösel M, Michler T, Wisskirchen K, Cheng X, Zhang K, Chou W, Wettengel JM, Malo A, Bohne F, Hoffmann D, Eyer F, Thimme R, Falk CS, Thasler WE, Heikenwalder M, Protzer U. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. Gastroenterology 2016;150:194-205. [DOI: 10.1053/j.gastro.2015.09.026] [Cited by in Crossref: 182] [Cited by in F6Publishing: 184] [Article Influence: 30.3] [Reference Citation Analysis]
100 Sun W, Zhong F, Zhi L, Zhou G, He F. Systematic -omics analysis of HBV-associated liver diseases. Cancer Lett. 2009;286:89-95. [PMID: 19144459 DOI: 10.1016/j.canlet.2008.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
101 Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol. 2008;8:20-25. [PMID: 17974504 DOI: 10.1016/j.meegid.2007.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
102 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
103 Moudi B, Heidari Z, Mahmoudzadeh-sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infection, Genetics and Evolution 2016;44:94-105. [DOI: 10.1016/j.meegid.2016.06.043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
104 Gao L, Chen X, Zhang L, Wu D, Zhao H, Niu J. Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population. Eur J Med Res 2016;21:23. [PMID: 27245049 DOI: 10.1186/s40001-016-0218-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
105 Feo F, De Miglio MR, Simile MM, Muroni MR, Calvisi DF, Frau M, Pascale RM. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim Biophys Acta 2006;1765:126-47. [PMID: 16216419 DOI: 10.1016/j.bbcan.2005.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 29] [Article Influence: 0.7] [Reference Citation Analysis]
106 Zhuo Y, Yang Y, Zhang M, Xu Y, Chen Z, Mu L, Tang X, Zhong Z, Chen J, Zhou L. Single Nucleotide Polymorphisms in IFN-γ Signaling Pathway Associated with Risk of Hepatitis B Virus Infection in Chinese Children. Can J Infect Dis Med Microbiol 2020;2020:8121659. [PMID: 32047575 DOI: 10.1155/2020/8121659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Ezzikouri S, Kitab B, Rebbani K, Marchio A, Wain-Hobson S, Dejean A, Vartanian JP, Pineau P, Benjelloun S. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population. J Viral Hepat. 2013;20:678-686. [PMID: 24010642 DOI: 10.1111/jvh.12042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
108 Jiang H, Cao F, Cao H, Rao Q, Yang Y. Associations of human leukocyte antigen and interleukin-18 gene polymorphisms with viral load in patients with hepatitis B infection. Medicine (Baltimore) 2018;97:e11249. [PMID: 30045250 DOI: 10.1097/MD.0000000000011249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Yang Y, Luo C, Feng R, Bi S. The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2011;137:947-952. [PMID: 21107607 DOI: 10.1007/s00432-010-0959-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
110 Shi A, Zhang X, Xiao F, Zhu L, Yan W, Han M, Luo X, Chen T, Ning Q. CD56 bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a. J Viral Hepat 2018;25:1352-62. [DOI: 10.1111/jvh.12946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
111 Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, Takahashi A, Kamatani Y, Miki D, Abe H. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet. 2011;20:3884-3892. [PMID: 21750111 DOI: 10.1093/hmg/ddr301] [Cited by in Crossref: 156] [Cited by in F6Publishing: 155] [Article Influence: 14.2] [Reference Citation Analysis]
112 Ben Dhifallah I, Ayouni K, Najjar G, Chelbi H, Sadraoui A, Hammami W, Touzi H, Triki H. Interleukin IL-1B gene polymorphism in Tunisian patients with chronic hepatitis B infection: Association with replication levels. Microbiol Immunol 2020;64:512-9. [PMID: 31944355 DOI: 10.1111/1348-0421.12774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Singh H, Marathe SD, Nain S, Nema V, Ghate MV, Gangakhedkar RR. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India. APMIS 2016;124:881-7. [PMID: 27522954 DOI: 10.1111/apm.12578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC. Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis. 2009;30:758-762. [PMID: 19126646 DOI: 10.1093/carcin/bgn286] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
115 Chen MF, Xia YC, Lin Y, Sun C, Yang DL, Wu J. An IFN-γ knockout mouse model of HBV persistence. Shijie Huaren Xiaohua Zazhi 2013; 21(31): 3394-3399 [DOI: 10.11569/wcjd.v21.i31.3394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Zhang X, Hong X, Deng G, Bai X. Single nucleotide polymorphisms and functional analysis of class II transactivator (CIITA) promoter IV in persistent HBV infection. J Clin Virol 2007;40:197-201. [PMID: 17919972 DOI: 10.1016/j.jcv.2007.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
117 Saxena R, Chawla YK, Verma I, Kaur J. IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India. Mol Cell Biochem. 2014;385:297-307. [PMID: 24101445 DOI: 10.1007/s11010-013-1838-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
118 Song QL, He XX, Yang H, Li J, Chen M, Wang MY, Liu Q, Yu JL, Yao JJ, Liu LF, Sun SZ, Lin JS. Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunol 2012;25:73-8. [PMID: 22225470 DOI: 10.1089/vim.2011.0053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
119 Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sökmen M. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C. Int J Infect Dis. 2013;17:e44-e49. [PMID: 23040881 DOI: 10.1016/j.ijid.2012.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
120 Zhang T, Zhang W, Zhao Y, Pan F, Gao Y, Yuan H, Liu X, Chen X, Zeng C, Liu L, Chen Y. Gene variation in IL10 and susceptibility to chronic hepatitis B. Journal of Infection 2014;69:75-80. [DOI: 10.1016/j.jinf.2014.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
121 Kalani M, Choopanizadeh M, Rasouli M. Influence of genetic variants of gamma interferon, interleukins 10 and 12 on Visceral Leishmaniasis in an endemic area, Iran. Pathog Glob Health 2019;113:14-9. [PMID: 30644801 DOI: 10.1080/20477724.2019.1568034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
122 Liu JJ, Gao YT, Du Z, Yang B, Jing X, Wang YJ, Wang FM, Liu T. Relationship between IL-10 gene promoter polymorphisms and outcome of hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1656-1663 [DOI: 10.11569/wcjd.v18.i16.1656] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Liu WC, Liu QY. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 6252-6261 [PMID: 24876746 DOI: 10.3748/wjg.v20.i20.6252] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
124 Li M, Zhuo Y, Xu Y, Chen H, Cheng Z, Zhou L. Genetic Association of Interleukin-6 Polymorphism (rs1800796) with Chronic Hepatitis B Virus Infection in Chinese Han Population. Viral Immunol 2021;34:267-72. [PMID: 33305999 DOI: 10.1089/vim.2020.0211] [Reference Citation Analysis]
125 Yuan L, Wang T, Zhang Y, Liu X, Zhang T, Li X, Liu P, Wu K, Shih JW, Yuan Q, Cheng T, Xia N. An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice. Exp Anim 2016;65:373-82. [PMID: 27264142 DOI: 10.1538/expanim.16-0013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
126 Cheong JY, Cho SW, Choi JY, Lee JA, Kim MH, Lee JE, Hahm KB, Kim JH. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci. 2007;22:529-535. [PMID: 17596666 DOI: 10.3346/jkms.2007.22.3.529] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
127 Matsuura K, Isogawa M, Tanaka Y. Host genetic variants influencing the clinical course of hepatitis B virus infection. J Med Virol. 2016;88:371-379. [PMID: 26255971 DOI: 10.1002/jmv.24350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
128 Xiao Q, Fu B, Chen P, Liu ZZ, Wang W, Ye Q. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) 2016;95:e5609. [PMID: 27977601 DOI: 10.1097/MD.0000000000005609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
129 Jiang X, Ma Y, Cui W, Li MD. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Amino Acids 2014;46:1819-26. [DOI: 10.1007/s00726-014-1767-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
130 Cheong JY, Cho SW, Lee JA, Lee KJ, Wang HJ, Lee JE, Kim JH. Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection. J Korean Med Sci. 2008;23:61-65. [PMID: 18303200 DOI: 10.3346/jkms.2008.23.1.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
131 Zhang PA, Wu JM, Li Y, Yang XS. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005; 11(11): 1594-1598 [PMID: 15786533 DOI: 10.3748/wjg.v11.i11.1594] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
132 Uhmn S, Kim D, Ko Y, Cho S, Cheong J, Kim J. A study on application of single nucleotide polymorphism and machine learning techniques to diagnosis of chronic hepatitis. Expert Systems 2009;26:60-9. [DOI: 10.1111/j.1468-0394.2008.00491.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, Stayoussef M, Yacoubi-Loueslati B. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene 2015;568:140-5. [PMID: 25982858 DOI: 10.1016/j.gene.2015.05.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
134 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(12): 2778-2781 [DOI: 10.11569/wcjd.v12.i12.2778] [Reference Citation Analysis]
135 Shi Z, Du C. Tumor necrosis factor alpha 308 G/A polymorphism and hepatocellular carcinoma risk in a Chinese population. Genet Test Mol Biomarkers. 2011;15:569-572. [PMID: 21401328 DOI: 10.1089/gtmb.2011.0008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
136 Chen K, Wei Y, Yang H, Li B. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genet Test Mol Biomarkers 2011;15:251-5. [PMID: 21186997 DOI: 10.1089/gtmb.2010.0208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
137 Song LH, Toan NL, Xuan NT, Uhlemann A, Boldt AB, Duy DN, Binh VQ, Kremsner PG, Kun JF. A promoter polymorphism in the interferon α-2 gene is associated with the clinical presentation of hepatitis B. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006;601:137-43. [DOI: 10.1016/j.mrfmmm.2006.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
138 Zhang PA, Li Y, Xu P, Wu JM. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J Gastroenterol 2004; 10(12): 1826-1829 [PMID: 15188516 DOI: 10.3748/wjg.v10.i12.1826] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
139 Allam G, Alsulaimani AA, Alzaharani AK, Nasr A. Neonatal infections in Saudi Arabia: Association with cytokine gene polymorphisms. Cent Eur J Immunol 2015;40:68-77. [PMID: 26155186 DOI: 10.5114/ceji.2015.50836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
140 Dar SA, Akhter N, Haque S, Singh T, Mandal RK, Ramachandran VG, Bhattacharya SN, Banerjee BD, Das S. Tumor necrosis factor (TNF)-α -308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus: Case-control study and meta-analysis. Autoimmunity 2016;49:179-87. [PMID: 26761187 DOI: 10.3109/08916934.2015.1134512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
141 Zhang TC, Liu W, Liu XQ, Pan FM, Gao YF, Yan F, Li X. Single nucleotide polymorphisms rs2120131, rs4935047, and rs7095891 in the MBL2 gene show no association with susceptibility to chronic hepatitis B in a Chinese Han population. J Med Virol 2013;85:602-7. [PMID: 23417614 DOI: 10.1002/jmv.23514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
142 Gangwar R, Pandey S, Mittal RD. Association of interferon-gamma +874A polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG 2009;116:1671-7. [PMID: 19681846 DOI: 10.1111/j.1471-0528.2009.02307.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
143 Ismael AB, Mergani A, Salim A, Mostafa S, Alkafaween I. Interferon-γ receptor-1 gene promoter polymorphisms and susceptibility for brucellosis in Makkah region. Afr Health Sci 2018;18:1157-65. [PMID: 30766581 DOI: 10.4314/ahs.v18i4.36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
144 Yang J, Zhao N, Su NL, Sun JL, Lv TG, Chen ZB. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis 2012;44:465-9. [PMID: 22263663 DOI: 10.3109/00365548.2011.649490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
145 Wei Y, Liu F, Li B, Chen X, Ma Y, Yan L, Wen T, Xu M, Wang W, Yang J. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis. Dig Dis Sci. 2011;56:2227-2236. [PMID: 21336601 DOI: 10.1007/s10620-011-1617-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
146 Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 2005; 11(21): 3260-3263 [PMID: 15929178 DOI: 10.3748/wjg.v11.i21.3260] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
147 Ferreira Sda C, Chachá SG, Souza FF, Teixeira AC, Santana Rde C, Deghaide NH, Rodrigues S, Marano LA, Mendes-Junior CT, Zucoloto S, Donadi EA, Martinelli Ade L. IL-18, TNF, and IFN-γ alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med Virol 2015;87:1689-96. [PMID: 25952099 DOI: 10.1002/jmv.24225] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
148 Al-saffar OB, Bajlan JS, Ad'hiah AH. Association analysis of interleukin-1 single nucleotide polymorphisms in viral hepatitis of Iraqi patients. Meta Gene 2019;20:100546. [DOI: 10.1016/j.mgene.2019.100546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Shoraka S, Mohebbi SR, Hosseini SM, Hosseini Razavi A, Hatami Y, Sharifian A, Rostami-Nejad M, Asadzadeh Aghdaei H, Zali MR. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population. Microb Pathog 2019;128:263-7. [PMID: 30639626 DOI: 10.1016/j.micpath.2019.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Carroll MB. The impact of biologic response modifiers on hepatitis B virus infection. Expert Opin Biol Ther. 2011;11:533-544. [PMID: 21269234 DOI: 10.1517/14712598.2011.554810] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
151 Carroll MB, Forgione MA. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action. Clin Rheumatol. 2010;29:1021-1029. [PMID: 20556450 DOI: 10.1007/s10067-010-1523-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
152 El Awady MK, Anany MA, Esmat G, Zayed N, Tabll AA, Helmy A, El Zayady AR, Abdalla MS, Sharada HM, El Raziky M, El Akel W, Abdalla S, Bader El Din NG. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. J Gastroenterol Hepatol 2011;26:843-50. [PMID: 21182542 DOI: 10.1111/j.1440-1746.2010.06605.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
153 Ghasemi M, Kashani E, Fayyaz A, Attar M, Shahbazi M. Interleukin-1 alpha variation is associated with the risk of developing preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 2015;193:75-8. [DOI: 10.1016/j.ejogrb.2015.06.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
154 Chihab H, Badre W, Tahiri M, Jadid FZ, Zaidane I, Elfihry R, Marchio A, Pineau P, Ezzikouri S, Benjelloun S. IFNL4 rs12979860 polymorphism influences HBV DNA viral loads but not the outcome of HBV infection in Moroccan patients. Microbes Infect 2021;23:104802. [PMID: 33607264 DOI: 10.1016/j.micinf.2021.104802] [Reference Citation Analysis]
155 Carroll MB, Bond MI. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Semin Arthritis Rheum. 2008;38:208-217. [PMID: 18221983 DOI: 10.1016/j.semarthrit.2007.10.011] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 6.2] [Reference Citation Analysis]
156 Kamali-Sarvestani E, Merat A, Talei AR. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-αlpha and TNF-beta) and gamma interferon (IFN-γamma) among Iranian women with breast cancer. Cancer Lett. 2005;223:113-119. [PMID: 15890243 DOI: 10.1016/j.canlet.2004.09.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
157 Sun Y, Lu Y, Xie L, Deng Y, Li S, Qin X. Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population. Cancer Cell Int 2015;15:35. [PMID: 25861244 DOI: 10.1186/s12935-015-0184-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
158 Tavakolpour S, Sali S. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis. Hepat Mon 2016;16:e33537. [PMID: 27257425 DOI: 10.5812/hepatmon.33537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
159 Xiao Y, Liu G, Gong L. Systematic Review and Meta-Analysis on the Association between Polymorphisms in Genes of IL-12 Signaling Pathway and Hepatocellular Carcinoma Risk. J Cancer 2018;9:3583-92. [PMID: 30310516 DOI: 10.7150/jca.26419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
160 Vandenbroeck K, Goris A. The IFNG–IL26–IL22 Cytokine Gene Cluster. In: Vandenbroeck K, editor. Cytokine Gene Polymorphisms in Multifactorial Conditions. CRC Press; 2006. pp. 157-74. [DOI: 10.1201/9781420005325.ch12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
161 Zhou J, Chen DQ, Poon VK, Zeng Y, Ng F, Lu L, Huang JD, Yuen KY, Zheng BJ. A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection. Immunogenetics. 2009;61:423-430. [PMID: 19488747 DOI: 10.1007/s00251-009-0377-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
162 Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E, Bignulin S, Fornasiere E, Fumolo E, Minisini R, Pirisi M, Toniutto P. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics. 2011;63:33-41. [PMID: 21072509 DOI: 10.1007/s00251-010-0491-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
163 Mosaad YM, Fathy H, Fawzy Z, El-Saied MA. Tumor necrosis factor-α -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus. Hum Immunol 2012;73:560-5. [PMID: 22365967 DOI: 10.1016/j.humimm.2012.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
164 Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H. Interferon gamma gene polymorphisms and chronic hepatitis B infections in an Iranian population. Turk J Gastroenterol 2020;31:515-21. [PMID: 32897225 DOI: 10.5152/tjg.2020.181024] [Reference Citation Analysis]
165 Zhang X, Jia J, Dong J, Yu F, Ma N, Li M, Liu X, Liu W, Li T, Liu D. HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy. J Viral Hepat. 2014;21:491-498. [PMID: 24750255 DOI: 10.1111/jvh.12159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
166 Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163-1169. [PMID: 16824070 DOI: 10.1111/j.1440-1746.2006.04304.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
167 Ranjbar M, Alizadeh AHM, Hajilooi M, Mousavi SM. Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran. World J Gastroenterol 2006; 12(31): 5044-5047 [PMID: 16937503 DOI: 10.3748/wjg.v12.i31.5044] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
168 Zhou J, Lu L, Yuen MF, Lam TW, Chung CP, Lam CL, Zhang B, Wang S, Chen Y, Wu SH. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J Hepatol. 2007;46:198-205. [PMID: 17125879 DOI: 10.1016/j.jhep.2006.08.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
169 Burckart GJ, Hutchinson IV, Zeevi A. Pharmacogenomics and lung transplantation: clinical implications. Pharmacogenomics J 2006;6:301-10. [DOI: 10.1038/sj.tpj.6500376] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]